Behandlung von Benigne Prostatahyperplasie (BPH) in China — erhalten Sie 3 personalisierte Klinikempfehlungen

Chinese hospitals treat benign prostatic hyperplasia using a combination of Western pharmaceuticals, minimally invasive surgeries, and traditional medicine. Standard protocols include alpha-blockers like Tamsulosin and 5-alpha reductase inhibitors like Finasteride. JCI-accredited facilities in Beijing and Guangzhou also offer advanced robotic-assisted prostatectomy.

• First-line medication: Doctors use Finasteride and Tamsulosin to reduce prostate size and improve flow.
• Surgical gold standard: Transurethral resection of the prostate remains the primary surgical intervention across China.
• Laser enucleation: Advanced centers utilize Holmium and Thulium lasers for safer treatment of large prostates.
• Robotic systems: Some Class A level III hospitals perform complex cases using da Vinci technology.

Bookimed Expert Insight: Yanda International Hospital and Fuda Cancer Hospital demonstrate how China bridges high-tech and traditional care. While Yanda serves 2,500,000 patients annually using 28,500 technologies, experts like Dr. Wang He Tian integrate specialized andrology knowledge. Patients should prioritize Class A level III clinics in Tier-1 cities to access both JCI safety standards and high-volume surgical expertise.

Patient Consensus: Patients note it is important to verify surgeon volume and often choose Tier-1 cities for laser procedures. Many find that starting with cost-effective medications provides relief before considering surgical options like TURP or HoLEP.

Traditional Chinese Medicine (TCM) integrates into China's benign prostatic hyperplasia (BPH) care through a combined medicinal model. Physicians use herbal formulas and acupuncture alongside Western alpha-blockers to manage urinary symptoms. This integrative approach is standard in high-level JCI-accredited facilities like Yanda International Hospital.

• Symptom management: TCM is the primary intervention for mild symptoms (IPSS under 7).
• Integrated therapy: Moderate cases combine herbal medicine with Western 5-alpha-reductase inhibitors.
• Post-surgical recovery: Acupuncture and moxibustion reduce inflammation after procedures like Holmium laser enucleation.
• Clinical protocols: Standardized patent medicines like Qianliexin capsules target hormonal and inflammatory pathways.

Bookimed Expert Insight: Data from top-tier academic centers like Yanda International Hospital shows a unique structural advantage. Their TCM-Joint Center combines traditional expertise with over 28,500 modern technologies. This allows specialists like Prof. Wang He Tian to lead departments focused specifically on integrative urological care. Patients benefit from a system that balances herbal recovery protocols with advanced robotic surgery capabilities in one facility.

Patient Consensus: Patients note that doctors often start with 2–4 weeks of herbal therapy before considering surgery. They emphasize that staying consistent with nightly herbal decoctions is vital to avoid needing a catheter.

Leading Chinese centers like Yanda International Hospital and Fuda Cancer Hospital are globally recognized for high-volume benign prostatic hyperplasia treatment. These JCI-accredited facilities utilize advanced GreenLight laser vaporization and cryosurgery. Expert surgeons often manage over 9,000 procedures annually while maintaining rigorous safety standards.

• Hospital accreditation: JCI-accredited facilities like Yanda meet strict international patient safety protocols.
• Surgical volume: Yanda International Hospital performs over 9,000 operations annually for prostate-related conditions.
• Specialized technology: Centers offer GreenLight laser vaporization and robotic-assisted da Vinci prostatic adenomectomy.
• Expert leadership: Dr. Wang He Tian leads urology departments with extensive academic recognition.

Bookimed Expert Insight: Yanda International Hospital stands out by combining Western surgical precision with traditional protocols. It holds the Class A Level III status, which is the highest medical tier in China. This designation typically ensures access to the most advanced diagnostic equipment. Data shows it serves 2.5 million patients yearly, indicating a massive infrastructure for handling international volume.

Patient Consensus: Patients note that language support is essential when choosing Chinese tertiary centers for care. While surgical outcomes are praised, many recommend confirming English-speaking staff availability before arrival for complex procedures.

Chinese urologists recommend invasive therapy for Benign Prostatic Hyperplasia when conservative treatments fail. Diagnostic thresholds include a peak flow rate below 10 ml/s and residual urine exceeding 50 ml. Specialists also require a prostate volume over 50–80cc and high symptom scores before surgical intervention.

• Symptom severity: Invasive procedures require an International Prostate Symptom Score above 19.
• Volume threshold: Ultrasound must confirm a prostate volume between 50cc and 80cc.
• Urine retention: Doctors monitor post-void residual urine until it exceeds 200 ml.
• Clinical triggers: Recurring urinary tract infections or bladder stones justify immediate surgical intervention.

Bookimed Expert Insight: Clinical practice at Class A level III facilities like Yanda International Hospital often bridges traditional and modern standards. While general guidelines exist, specialists like Dr. Wang He Tian integrate Chinese medical books with international protocols. This approach often results in a meds-first strategy until physiological thresholds are strictly met. Patients should prepare for detailed tracking of monthly symptoms to support requests for advanced surgical escalations.

Patient Consensus: Patients note that doctors in Tier 1 cities often prioritize medical management with alpha-blockers. Many emphasize bringing complete medical records from home to avoid delays in surgical decision-making.

Newer Chinese laser techniques protect sexual function by using specific light wavelengths that limit thermal penetration. High-power 450 nm blue lasers and 1470 nm diode lasers minimize heat damage to erectile nerves. Modified surgical steps further spare the ejaculatory ducts and bladder neck mucosa.

• Blue laser vaporization: Minimizes tissue penetration depth to prevent heating nearby erectile nerves.
• Double-n HoLEP: Refines prostate separation to maintain antegrade ejaculation in most patients.
• Selective lobe preservation: Leaves tissue intact at the 11 to 1 o'clock positions.
• Verumontanum protection: Specifically spares the area where semen enters the urethra during surgery.

Bookimed Expert Insight: Leading Chinese urologists like Dr. Wang He Tian integrate Western laser technology with Traditional Chinese Medicine (TCM) protocols. Data from high-volume centers suggests that this multidisciplinary approach helps manage pelvic blood flow. Facilities like Tianjin Jin Xian Tan Hospital perform approximately 9,000 operations annually. This high procedural volume is a strong indicator of surgical precision in nerve-sparing techniques. Patients should prioritize hospitals with class A level III status to ensure access to these specific blue laser platforms.

Patient Consensus: Patients note it is important to ask about ejaculation-preserving modes before the procedure. Those who choose thulium or holmium lasers often track their own sexual health scores to ensure recovery remains on target.

Recovery after BPH surgery in China typically requires a 2 to 5-day hospital stay. Patients generally achieve full healing within 4 to 6 weeks. Short flights are possible after 10 days. Most experts recommend waiting 6 weeks before embarking on long-haul air travel.

• Hospital stay: Expect 2 to 4 days for monitoring and bladder irrigation at Chinese facilities.
• Catheter duration: Surgeons usually remove the urinary catheter between 3 and 7 days post-procedure.
• Activity milestones: Light walking is encouraged after 1 week. Avoid lifting over 10 kg until week 8.
• Flight readiness: Long-haul travel is safest after 6 weeks to minimize deep vein thrombosis risks.

Bookimed Expert Insight: While many Chinese centers like Yanda International Hospital offer traditional TURP, choosing laser-based procedures like Holmium Laser Enucleation can accelerate travel readiness. Our data shows these minimally invasive techniques often reduce catheter time to just 48 hours. This allows international patients to transition to local hotels faster than with conventional surgery.

Patient Consensus: Patients emphasize the need for a 1-hour trial car trip before booking flights. They often suggest waiting until week 10 for international travel to ensure any late-stage swelling has fully subsided.

Patients seeking treatment for benign prostatic hyperplasia in China should prioritize facilities with Tertiary Grade A (Class 3A) status. This national ranking ensures the highest standards for surgical equipment and clinical outcomes. International Joint Commission International (JCI) accreditation and National Medical Products Administration (NMPA) registration for lasers or robotic systems are also vital quality indicators.

• Hospital classification: Select Tertiary Grade A facilities for superior surgical infrastructure and patient safety.
• International accreditation: Verify Joint Commission International (JCI) seals to ensure global healthcare standards.
• Surgeon rank: Confirm the specialist is a Chief Physician or Associate Chief Physician.
• Device registration: Ensure all laser or microwave equipment has valid NMPA medical registration.

Bookimed Expert Insight: Data shows a significant gap between local ratings and international safety benchmarks. While many hospitals hold Class 3A status, only specialized centers like Yanda International Hospital or Fuda Cancer Hospital maintain Joint Commission International (JCI) accreditation. For complex prostate cases, choosing a JCI-accredited facility in Beijing or Guangzhou often provides better access to multi-lingual support and internationally audited safety protocols.

Patient Consensus: Patients emphasize the need to verify surgeon case volumes personally rather than relying solely on government approvals. Many note that prioritizing English-speaking hubs with clear international audits helps avoid communication gaps and ensures more reliable post-operative follow-up plans.